
Two Phases, One Strategy
How Blast Longevity Approaches Lung Fibrosis Pulmonary fibrosis is one of the most difficult conditions in regenerative medicine — not because the biology is mysterious, but because the disease is self-perpetuating. Once TGF-β and activin signaling take hold in the lung, fibroblasts convert to myofibroblasts, collagen accumulates, and the tissue’s own repair machinery starts working against it. Conventional anti-fibrotic drugs slow the decline. They do not reverse it, and they